Check Cap Stock

Check Cap FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Check Cap (MBAI) as of Jul 14, 2026 is 31.83 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 96.98 % — a change of -67.18% (lower).

FCF Conversion

31.83 %

YoY

-67.18%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Check Cap is 2026 31.83 % . FCF Conversion Rate (FCF/EBITDA) of Check Cap was 2025 96.98 % . It decreases by -67.18% lower compared to the previous year.
Access this data via the Eulerpool API

Check Cap Stock analysis

What does Check Cap do? Check Cap Ltd is an international biotech company specializing in the development of non-invasive diagnostic technologies for early detection of colon cancer. The company is headquartered in Israel and was founded in 2004. Check Cap is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Check Cap stock

FCF Conversion Rate (FCF/EBITDA) of Check Cap is 31.83 % in 2026.

Access this data via the Eulerpool API

Cash Flow — Check Cap

All Key Metrics — Check Cap